Jeff Salzman

Background

About Jeff Salzman

Accomplished clinical laboratory/diagnostics professional with broad experience and expertise in health policy, coverage, and reimbursement with public/government funded and private/commercial payers, including: • Greater than 25 years in health care; 8+ with private payers, 20+ within the clinical laboratory/molecular diagnostics/IVD industries (including start-ups and early stage companies) • Success with obtaining and expanding coverage with private payers, multiple CMS jurisdictions/Medicare Administrative Contractors (Noridian, Novitas, Palmetto), MolDx, numerous state Medicaid agencies, and laboratory benefit management companies • Billing and coding options, as well as patient assistance and appeals programs to expand coverage and reduce barriers for physician adoption • Evidence development and coverage determination required to obtain positive coverage and reimbursement (pre- and post-launch) for “experimental/investigational” diagnostic tests, including predictive molecular, proteomic, microarray, and ELISA assays • Laboratory-developed tests (“LDTs”) and FDA-cleared assays/test kits representing oncologic (breast, ovarian, prostate), infectious disease (HIV), and cardiovascular disease • PAMA/Protecting Access to Medicare Act leader